SCHEMBL12418337

SCHEMBL12418337

Cc1ccc(-c2ccc(S(=O)(=O)NC3CCC(O)CC3)cc2F)cc1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.56
TDP1 Q9NUW8 1/20 0.56
ALDH1A1 P00352 2/20 0.50
ALOX5AP P20292 2/20 0.50
FEN1 P39748 2/20 0.50
IDH2 P48735 3/20 0.49
CYP3A4 P08684 1/20 0.49
TSHR P16473 1/20 0.49
PIK3CD O00329 8/20 0.48
PIK3CB P42338 7/20 0.48
PIK3CG P48736 7/20 0.48
MTOR P42345 5/20 0.48
PIK3C3 Q8NEB9 4/20 0.48
PIK3CA P42336 1/20 0.48
PARG Q86W56 1/20 0.46
PIK3R2 O00459 1/20 0.45
PIK3R1 P27986 1/20 0.45
PIK3R3 Q92569 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23953188 1.00 KMT2A (0.56) KMT2ATDP1ALDH1A1ALOX5APFEN1
SCHEMBL16728062 0.88 PIK3CD (0.53) ALDH1A1CYP3A4TSHRPIK3CDPIK3CB
SCHEMBL2196383 0.87 KMT2A (0.52) KMT2ATDP1ALDH1A1ALOX5APFEN1
SCHEMBL2196387 0.87 KMT2A (0.52) KMT2ATDP1ALDH1A1ALOX5APFEN1
SCHEMBL16705632 0.86 KMT2A (0.53) KMT2ATDP1ALOX5APFEN1IDH2
SCHEMBL2196030 0.86 KMT2A (0.53) KMT2ATDP1ALOX5APFEN1IDH2
SCHEMBL2196024 0.86 KMT2A (0.53) KMT2ATDP1ALOX5APFEN1IDH2
SCHEMBL2194173 0.85 ALOX5AP (0.54) KMT2ATDP1ALOX5APFEN1IDH2
SCHEMBL2194991 0.85 ALOX5AP (0.54) KMT2ATDP1ALOX5APFEN1IDH2
SCHEMBL2194177 0.85 ALOX5AP (0.54) KMT2ATDP1ALOX5APFEN1IDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8435968-B2 Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use PIMCO 2664 LIMITED (GB) 2013-05-07 US disclosed
US-20110172189-A1 Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use PIMCO 2664 LIMITED (GB) 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172189-A1 Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use SOST, AADAC, ARSA KMT2A 1816/4885TDP1 3674/4885ALDH1A1 3408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.